Pricing

Sophiris Bio Inc (SPHS)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Randall E. Woods
Employees:
6
1258 PROSPECT STREET, LA JOLLA, CA, 92037
858-777-1760

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • PROTOX THERAPEUTICS INC. (TIER2)
Stock Split History
DateRatio
2013-08-15 1:52
Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which develops products for the treatment of urological diseases. It is currently developing PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms. The company was founded in May 2003 and is headquartered in La Jolla, CA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available